Jane Street
RLMD icon

Jane Street’s Relmada Therapeutics RLMD Stock Holding History

Jane Street’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-221,969
Closed -$1.54M – 12883
2026
Q1 		$1.54M Sell
221,969
-49,140
-18% -$232K ﹤0.01% 5577
2025
Q4 		$1.31M Buy
271,109
+185,442
+216% +$621K ﹤0.01% 5594
2025
Q3 		$172K Sell
85,667
-28,687
-25% -$27.5K ﹤0.01% 9783
2025
Q2 		$68.6K Buy
+114,354
New +$58.7K ﹤0.01% 9095
2024
Q3 		– Sell
-37,476
Closed -$112K – 10284
2024
Q2 		$112K Sell
37,476
-137,753
-79% -$498K ﹤0.01% 8684
2024
Q1 		$815K Buy
175,229
+163,094
+1,344% +$786K ﹤0.01% 5773
2023
Q4 		$50.2K Buy
+12,135
New +$35.9K ﹤0.01% 8777
2023
Q3 		– Sell
-12,118
Closed -$29.8K – 9264
2023
Q2 		$29.8K Buy
+12,118
New +$33.5K ﹤0.01% 8309
2023
Q1 		– Sell
-118,583
Closed -$414K – 9780
2022
Q4 		$414K Buy
+118,583
New +$1.04M ﹤0.01% 6466
2022
Q3 		– Sell
-12,348
Closed -$342K – 10335
2022
Q2 		$234K Sell
12,348
-43,395
-78% -$947K ﹤0.01% 7972
2022
Q1 		$1.5M Buy
+55,743
New +$1.15M ﹤0.01% 5288
2021
Q3 		– Sell
-18,919
Closed -$606K – 10595
2021
Q2 		$606K Buy
+18,919
New +$657K ﹤0.01% 6881
2020
Q3 		– Sell
-18,698
Closed -$836K – 7799
2020
Q2 		$836K Buy
18,698
+10,762
+136% +$455K ﹤0.01% 4324
2020
Q1 		$271K Buy
+7,936
New +$320K ﹤0.01% 4321

Other funds holding RLMD

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street's RLMD Position: Q2 2026 in Review

Jane Street sold out of Relmada Therapeutics (RLMD) in Q2 2026, closing a stake of 221,969 shares — an estimated $1.54M sold.

Jane Street first reported a position in RLMD in Q1 2020 and held it in 14 quarters. The position peaked at $1.54M in Q1 2026. 126 funds tracked by Wall St. Rank hold RLMD as of Q2 2026.

  • Jane Street reported no remaining Relmada Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 221,969 Relmada Therapeutics shares in Q2 2026, an estimated $1.54M.
  • Jane Street first reported a position in Relmada Therapeutics in Q1 2020 and held it in 14 quarters.
  • Jane Street's Relmada Therapeutics position peaked at $1.54M in Q1 2026.
  • 126 funds tracked by Wall St. Rank held Relmada Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.